Table 2 Per-protocol analysis of chloroquine efficacy to treat P. vivax malaria in the Saharan zone in Mauritania
From: Efficacy of chloroquine for the treatment of Plasmodium vivax in the Saharan zone in Mauritania
Outcome | Nouakchott | Atar |
|---|---|---|
Number of enrolled patients | 67 | 61 |
Exclusion after enrollment, n (%) | 3 (4.5) | 0 |
Lost-to-follow-up, n (%) | 2 (3.0) | 4 (6.6) |
Per protocol population, n | 62 | 57 |
PCR-uncorrected outcome* | ||
Early treatment failure, n (%) | 0 | 0 |
Late clinical failure (LCF), n (%) | 0 | 0 |
Late parasitological failure, n (%) | 0 | 0 |
Adequate clinical and parasitological response, n (%) | 62 (100) | 57 (100) |